Neurogenin-3 is a protein that in humans is encoded by the NEUROG3gene.[1]
Neurogenin-3 is expressed in endocrine progenitor cells and is required for endocrine cell development in the pancreas and intestine.[2] It belongs to a family of basic helix-loop-helix (bHLH) transcription factors involved in the determination of neural precursor cells in the neuroectoderm.[3]
Neurogenin 3 (NGN3) is expressed by 2-10% of acinar and duct cells in the histologically normal adult human pancreas. NGN3+ cells isolated from cultured exocrine tissue by coexpressed cell surface glycoprotein CD133 have a transcriptome consistent with exocrine dedifferentiation, a phenotype that resembles endocrine progenitor cells during development, and a capacity for endocrine differentiation in vitro.[4] Human[5] and rodent[6][7][8][9][10][11][12][13][14] exocrine cells have been reprogrammed into cells with an islet cell-like phenotype following direct expression of NGN3 or manipulation that leads to its expression.
↑Xu X, D'Hoker J, Stangé G, Bonné S, De Leu N, Xiao X, Van de Casteele M, Mellitzer G, Ling Z, Pipeleers D, Bouwens L, Scharfmann R, Gradwohl G, Heimberg H (Jan 2008). "Beta cells can be generated from endogenous progenitors in injured adult mouse pancreas". Cell. 132 (2): 197–207. doi:10.1016/j.cell.2007.12.015. PMID18243096.
↑Baeyens L, Bonné S, German MS, Ravassard P, Heimberg H, Bouwens L (Nov 2006). "Ngn3 expression during postnatal in vitro beta cell neogenesis induced by the JAK/STAT pathway". Cell Death and Differentiation. 13 (11): 1892–9. doi:10.1038/sj.cdd.4401883. PMID16514419.
↑Zhou Q, Brown J, Kanarek A, Rajagopal J, Melton DA (Oct 2008). "In vivo reprogramming of adult pancreatic exocrine cells to beta-cells". Nature. 455 (7213): 627–32. doi:10.1038/nature07314. PMID18754011.
Lejonklou MH, Edfeldt K, Johansson TA, Stålberg P, Skogseid B (Apr 2009). "Neurogenin 3 and neurogenic differentiation 1 are retained in the cytoplasm of multiple endocrine neoplasia type 1 islet and pancreatic endocrine tumor cells". Pancreas. 38 (3): 259–66. doi:10.1097/MPA.0b013e3181930818. PMID19307926.
del Bosque-Plata L, Lin J, Horikawa Y, Schwarz PE, Cox NJ, Iwasaki N, Ogata M, Iwamoto Y, German MS, Bell GI (Mar 2001). "Mutations in the coding region of the neurogenin 3 gene (NEUROG3) are not a common cause of maturity-onset diabetes of the young in Japanese subjects". Diabetes. 50 (3): 694–6. doi:10.2337/diabetes.50.3.694. PMID11246894.
Cauchi S, Proença C, Choquet H, Gaget S, De Graeve F, Marre M, Balkau B, Tichet J, Meyre D, Vaxillaire M, Froguel P (Mar 2008). "Analysis of novel risk loci for type 2 diabetes in a general French population: the D.E.S.I.R. study". Journal of Molecular Medicine. 86 (3): 341–8. doi:10.1007/s00109-007-0295-x. PMID18210030.
Jensen JN, Hansen L, Ekstrøm CT, Pociot F, Nerup J, Hansen T, Pedersen O (Jan 2001). "Polymorphisms in the neurogenin 3 gene (NEUROG) and their relation to altered insulin secretion and diabetes in the Danish Caucasian population". Diabetologia. 44 (1): 123–6. doi:10.1007/s001250051589. PMID11206403.
Louet JF, Smith SB, Gautier JF, Molokhia M, Virally ML, Kevorkian JP, Guillausseau PJ, Vexiau P, Charpentier G, German MS, Vaisse C, Urbanek M, Mauvais-Jarvis F (Sep 2008). "Gender and neurogenin3 influence the pathogenesis of ketosis-prone diabetes". Diabetes, Obesity & Metabolism. 10 (10): 912–20. doi:10.1111/j.1463-1326.2007.00830.x. PMID18093211.
Yokoi N, Kanamori M, Horikawa Y, Takeda J, Sanke T, Furuta H, Nanjo K, Mori H, Kasuga M, Hara K, Kadowaki T, Tanizawa Y, Oka Y, Iwami Y, Ohgawara H, Yamada Y, Seino Y, Yano H, Cox NJ, Seino S (Aug 2006). "Association studies of variants in the genes involved in pancreatic beta-cell function in type 2 diabetes in Japanese subjects". Diabetes. 55 (8): 2379–86. doi:10.2337/db05-1203. PMID16873704.
Milord E, Gragnoli C (Oct 2006). "NEUROG3 variants and type 2 diabetes in Italians". Minerva Medica. 97 (5): 373–8. PMID17146417.
Li J, Bergmann A, Reimann M, Schulze J, Bornstein SR, Schwarz PE (Mar 2008). "Genetic variation of Neurogenin 3 is slightly associated with hyperproinsulinaemia and progression toward type 2 diabetes". Experimental and Clinical Endocrinology & Diabetes. 116 (3): 178–83. doi:10.1055/s-2007-992156. PMID18072012.
Dror V, Nguyen V, Walia P, Kalynyak TB, Hill JA, Johnson JD (Dec 2007). "Notch signalling suppresses apoptosis in adult human and mouse pancreatic islet cells". Diabetologia. 50 (12): 2504–15. doi:10.1007/s00125-007-0835-5. PMID17922104.
Jackson AE, Cassell PG, North BV, Vijayaraghavan S, Gelding SV, Ramachandran A, Snehalatha C, Hitman GA (Aug 2004). "Polymorphic variations in the neurogenic differentiation-1, neurogenin-3, and hepatocyte nuclear factor-1alpha genes contribute to glucose intolerance in a South Indian population". Diabetes. 53 (8): 2122–5. doi:10.2337/diabetes.53.8.2122. PMID15277395.
Okada T, Tobe K, Hara K, Yasuda K, Kawaguchi Y, Ikegami H, Ito C, Kadowaki T (Feb 2001). "Variants of neurogenin 3 gene are not associated with Type II diabetes in Japanese subjects". Diabetologia. 44 (2): 241–4. doi:10.1007/s001250051606. PMID11270683.
Sommer L, Ma Q, Anderson DJ (1996). "neurogenins, a novel family of atonal-related bHLH transcription factors, are putative mammalian neuronal determination genes that reveal progenitor cell heterogeneity in the developing CNS and PNS". Molecular and Cellular Neurosciences. 8 (4): 221–41. doi:10.1006/mcne.1996.0060. PMID9000438.